Serotonin transporter gene polymorphism and treatment response to serotonin reuptake inhibitor (escitalopram) in depression: An open pilot study
Author(s) -
MushtaqA Margoob,
Dhuha Mushtaq,
Imtiyaz Murtza,
Huda Mushtaq,
Arif Ali
Publication year - 2008
Publication title -
indian journal of psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.485
H-Index - 34
eISSN - 1998-3794
pISSN - 0019-5545
DOI - 10.4103/0019-5545.39759
Subject(s) - escitalopram , serotonin transporter , serotonin reuptake inhibitor , serotonin , citalopram , reuptake inhibitor , serotonin plasma membrane transport proteins , psychology , polymorphism (computer science) , medicine , pharmacology , genotype , psychiatry , gene , biology , antidepressant , genetics , receptor , anxiety
Blocking of the serotonin transporter is the main mechanism of action of SSRIs; therefore, the gene encoding this protein is a strong candidate for a possible genetic influence on the treatment response.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom